The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.
Toxicity of cationic lipids and cationic polymers in gene delivery
Abstract
Gene therapy, as a promising therapeutics to treat genetic or acquired diseases, has achieved exciting development in the past two decades. Appropriate gene vectors can be crucial for gene transfer. Cationic lipids and polymers, the most important non-viral vectors, have many advantages over viral ones as non-immunogenic, easy to produce and not oncogenic. They hold the promise to replace viral vectors to be used in clinic. However, the toxicity is still an obstacle to the application of non-viral vectors to gene therapy. For overcoming the problem, many new cationic compounds have been developed. This article provides a review with respect to toxicity of cationic lipids and polymers in gene delivery. We evaluate the structural features of cationic compounds and summarize the relationship of toxicity and structure and hope to provide available suggestions on the development of these cationic compounds.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PEGylated, neutral, and ionizable lipids are employed as stable carriers in lipid delivery systems designed specifically for siRNA, despite toxicity, complement activation, and poor biological distribution also encouraging their development.317,318”
From Smart nanoparticles for cancer therapy (2023) · cites this paper as [317]
In the citing paper
“Based on the potential toxicity of liposomes in clinical application,25,26 the success of the first approved small interfering RNA-lipid nanoparticle (LNP) therapeutic27 and mRNA COVID-19 vaccines originates only from their delivery using ionizable lipid-containing LNPs,28, 29, 30”
From COVID-19 mRNA vaccines: Platforms and current developments (2022) · cites this paper as [25]
In the citing paper
“Cytotoxicity of lipid materials is also a safety concern, depending on the dose, lipid properties and cell types176,177.”
From Lipid nanoparticles for mRNA delivery (2021) · cites this paper as [176]
Citations
Cites
Boussif, O., Lezoualc’h, F., Zanta, M. A., Djavaheri‐Mergny, M., Scherman, D., DEMENEIX, B. A., & Behr, J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7297 · Cited by 6,256
Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.
Felgner, P. L., Gadek, T. R., Holm, M., Roman, R., Chan, H. W., Wenz, M., Northrop, J. P., RINGOLD, G. M., & Danielsen, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7413 · Cited by 4,954
Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations.
Felgner, J. H., Kumar, R., Sridhar, C. N., Wheeler, C. J., Tsai, Y.-L., Border, R., Ramsey, P., Martin, M. U., & Felgner, P. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41980-6 · Cited by 1,313
Fischer, D., Bieber, T., Li, Y., Elsässer, H., & Kissel, T. (1999) · Pharmaceutical Research · doi:10.1023/a:1014861900478 · Cited by 1,219
Poly(ethylenimine) and its role in gene delivery
Godbey, W. T., Wu, K. K., & Mikos, A. G. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00090-5 · Cited by 1,200
Polyethylenimine-based non-viral gene delivery systems
Lungwitz, U., Breunig, M., Blunk, T., & Göpferich, A. M. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.11.011 · Cited by 998
Receptor-mediated in vitro gene transformation by a soluble DNA carrier system.
Wu, G. Y., & Wu, C. H. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61209-8 · Cited by 855
Godbey, W. T., Wu, K. K., & Mikos, A. G. (1999) · Journal of Biomedical Materials Research · doi:10.1002/(sici)1097-4636(19990605)45:3 · Cited by 833
Kunath, K. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00076-2 · Cited by 809
Effect of Chitosan on the Permeability of Monolayers of Intestinal Epithelial Cells (Caco-2)
Artursson, P., Lindmark, T., Davis, S. S., & Illum, L. (1994) · Pharmaceutical Research · doi:10.1023/a:1018967116988 · Cited by 766
Flagged first, then by citations
Research works printed but not linked: 1
- Hong, 1997, Stabilisation of cationic liposome/DNA complexes by polyamines and polyethyleneglycol–phospholipid conjugates for efficient in vivo gene delivery, FEBS Lett., 414, 187
Cited by
Sorted by citations
Items 501–600 of 1,000
Cell Response to the Exposure to Chitosan–TPP//Alginate Nanogels
Schütz, C. A., Juillerat‐Jeanneret, L., Käuper, P., & Wandrey, C. (2011) · Biomacromolecules · doi:10.1021/bm201231x · Cited by 64
Structure-Based Design of Dendritic Peptide Bolaamphiphiles for siRNA Delivery
Zeng, H., Johnson, M. E., Oldenhuis, N. J., Tiambeng, T. N., & Guan, Z. (2015) · ACS Central Science · doi:10.1021/acscentsci.5b00233 · Cited by 64
Singla, P., Singh, O., Chabba, S., Aswal, V. K., & Mahajan, R. K. (2017) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2017.10.015 · Cited by 64
Sun, Y., Li, X., Zhang, L., Liu, X., Jiang, B., Long, Z., & Jiang, Y. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b01123 · Cited by 64
Non-viral transfection technologies for next-generation therapeutic T cell engineering
Raes, L., Smedt, S. C. D., Raemdonck, K., & Braeckmans, K. (2021) · Biotechnology Advances · doi:10.1016/j.biotechadv.2021.107760 · Cited by 67
Exploiting the placenta for nanoparticle-mediated drug delivery during pregnancy
Figueroa‐Espada, C. G., Hofbauer, S. I., Mitchell, M. J., & Riley, R. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.09.006 · Cited by 65
Branched Antisense and siRNA Co‐Assembled Nanoplatform for Combined Gene Silencing and Tumor Therapy
Liu, J., Lu, X., Wu, T., Wu, X., Han, L., & Ding, B. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202011174 · Cited by 64
Advances in cancer theranostics using organic-inorganic hybrid nanotechnology
Chen, G., Qian, Y., Zhang, H., Ullah, A., He, X., Zhou, Z., Fenniri, H., & Shen, J. (2021) · Applied Materials Today · doi:10.1016/j.apmt.2021.101003 · Cited by 63
A Simple and Quick Method for Loading Proteins in Extracellular Vesicles
Busatto, S., Iannotta, D., Walker, S. A., Marzio, L. D., & Wolfram, J. (2021) · Pharmaceuticals · doi:10.3390/ph14040356 · Cited by 64
Illuminating RNA trafficking and functional delivery by extracellular vesicles
de Voogt, W. S., Tanenbaum, M. E., & Vader, P. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.04.017 · Cited by 65
Development of lipid nanoparticles and liposomes reference materials (II): cytotoxic profiles
Krishnapriya, S., Jakubek, Z. J., Chen, S., Zaifman, J., Tam, Y. Y. C., & Zou, S. (2022) · Scientific Reports · doi:10.1038/s41598-022-23013-2 · Cited by 68
mRNA-Based Therapeutics in Cancer Treatment
Sun, H., Zhang, Y., Wang, G., Yang, W., & Xu, Y. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020622 · Cited by 65
Avais, M., & Chattopadhyay, S. (2019) · Polymer · doi:10.1016/j.polymer.2019.121701 · Cited by 62
Zhuo, Z., Guo, K., Luo, Y., Yang, Q., Wu, H., Zeng, R., Jiang, R., Li, J., Wei, R., Lian, Q., et al. (2023) · Theranostics · doi:10.7150/thno.87739 · Cited by 62
Vighi, E., Ruozi, B., Montanari, M., Battini, R., & Leo, E. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.01.030 · Cited by 62
Calarco, A., Bosetti, M., Margarucci, S., Fusaro, L., Nicolì, E., Petillo, O., Cannas, M. F., Galderisi, U., & Peluso, G. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2012.12.019 · Cited by 62
A pH-responsive cyclodextrin-based hybrid nanosystem as a nonviral vector for gene delivery
Chen, H., Liu, X., Dou, Y., He, B., Liu, L., Wei, Z., Li, J., Wang, C., Mao, C., Zhang, J., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.02.035 · Cited by 63
Liu, Q., Jia, J., Yang, T., Fan, Q., Wang, L., & Ma, G. (2016) · Small · doi:10.1002/smll.201503662 · Cited by 62
Alhoranta, A. M., Lehtinen, J., Urtti, A. O., Butcher, S. J., Aseyev, V. O., & Tenhu, H. J. (2011) · Biomacromolecules · doi:10.1021/bm2006906 · Cited by 62
Chernousova, S., & Epple, M. (2017) · Gene Therapy · doi:10.1038/gt.2017.13 · Cited by 62
Rational Design of DNA Framework‐Based Hybrid Nanomaterials for Anticancer Drug Delivery
Wang, C., Yu, Y., Irfan, M., Xu, B., Li, J., Zhang, L., Qin, Z. S., Yu, C., Liu, H., & Su, X. (2020) · Small · doi:10.1002/smll.202002578 · Cited by 62
Nanomaterials for Treating Bacterial Biofilms on Implantable Medical Devices
Tran, H. M., Tran, H. A., Booth, M. A., Fox, K. E., Nguyen, H. T., Tran, N. L., & Tran, P. A. (2020) · Nanomaterials · doi:10.3390/nano10112253 · Cited by 63
Richter, F., Leer, K., Martin, L., Mapfumo, P. P., Solomun, J. I., Kuchenbrod, M. T., Hoeppener, S., Brendel, J. C., & Traeger, A. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00994-2 · Cited by 61
Markov, O. V., Mironova, N. L., Maslov, M. A., Petukhov, I. A., Morozova, N. G., Vlassov, V. V., & Аркадьевна, З. М. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.11.034 · Cited by 63
Core‐shell particles with glycopolymer shell and polynucleoside core via RAFT: From micelles to rods
Pearson, S., Allen, N., & Stenzel, M. H. (2009) · Journal of Polymer Science Part A Polymer Chemistry · doi:10.1002/pola.23275 · Cited by 61
Lim, D. G., Rajasekaran, N., Lee, D., Kim, N. A., Jung, H. S., Hong, S., Shin, Y. K., Kang, E., & Jeong, S. H. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b09624 · Cited by 61
Baharifar, H., Khoobi, M., Bidgoli, S. A., & Amani, A. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.11.157 · Cited by 61
Li, X., Zhang, Y., Liu, G., Luo, Z., Zhou, L. J., Xue, Y., & Liu, M. (2022) · RSC Advances · doi:10.1039/d2ra00566b · Cited by 60
Genetically Engineered‐Cell‐Membrane Nanovesicles for Cancer Immunotherapy
Cheng, Q., Kang, Y., Yao, B. W., Dong, J., Zhu, Y., He, Y., & Ji, X. (2023) · Advanced Science · doi:10.1002/advs.202302131 · Cited by 60
Targeting materials and strategies for RNA delivery
Lin, L., Su, K., Cheng, Q., & Liu, S. (2023) · Theranostics · doi:10.7150/thno.87316 · Cited by 61
Target delivery of a gene into the brain using the RVG29-oligoarginine peptide
Cheng, G., Li, X., Xu, L., & Zhang, Y.-H. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.12.017 · Cited by 63
Mani, T., Tircsó, G., Togao, O., Zhao, P., Soesbe, T. C., Takahashi, M., & Sherry, A. D. (2009) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.279 · Cited by 60
Phospholipids in pulmonary drug delivery
Wauthoz, N., & Amighi, K. (2014) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.201300368 · Cited by 60
Polymers in gene therapy technology
Hosseinkhani, H., Abedini, F., Ou, K., & Domb, A. J. (2014) · Polymers for Advanced Technologies · doi:10.1002/pat.3432 · Cited by 61
Not miR-ly small RNAs: Big potential for microRNAs in therapy
Love, T. M., Moffett, H. F., & Novina, C. D. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.12.1167 · Cited by 60
Design of Starch-graft-PEI Polymers: An Effective and Biodegradable Gene Delivery Platform
Yamada, H., Loretz, B., & Lehr, C. (2014) · Biomacromolecules · doi:10.1021/bm500128k · Cited by 60
Polymers for DNA Vaccine Delivery
Zhang, M., Hong, Y., Chen, W., & Wang, C. (2016) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.6b00418 · Cited by 61
Wu, X., Li, Y., Chen, X., Zhou, Z., Pang, J., Luo, X., & Kong, M. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb00448c · Cited by 62
Albumin-based nanoconjugates for targeted delivery of therapeutic oligonucleotides
Ming, X., Carver, K. A., & Wu, L. H. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.06.066 · Cited by 60
Structure-function relationships of nonviral gene vectors: Lessons from antimicrobial polymers
Xing, H., Lu, M., Yang, T., Liu, H., Sun, Y., Zhao, X., Xu, H., Yang, L., & Ding, P. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.12.041 · Cited by 59
Guo, W., Gao, H., Li, H., Ge, S., Zhang, F., Wang, L., Shi, H., & Han, A. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c06001 · Cited by 60
Innovative Strategies for Drug Delivery to the Ocular Posterior Segment
Gabai, A., Zeppieri, M., Finocchio, L., & Salati, C. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071862 · Cited by 59
Deshmukh, R., Sethi, P., Singh, B., Shiekmydeen, J., Salave, S., Patel, R. J., Ali, N., Rashid, S., Elossaily, G. M., & Kumar, A. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16081076 · Cited by 60
Fusogenic lipid nanoparticles for rapid delivery of large therapeutic molecules to exosomes
Son, G., Song, J., Park, J. C., Kim, H. N., & Kim, H. (2025) · Nature Communications · doi:10.1038/s41467-025-59489-5 · Cited by 59
Li, J., Ji, Mao, Z., Wang, Zhang, W., & Su, H. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s42440 · Cited by 60
Yang, C., Thomsen, R. P., Ogaki, R., Kjems, J., & Teo, B. M. (2015) · Journal of Materials Chemistry B · doi:10.1039/c5tb00467e · Cited by 59
Depieri, L. V., Borgheti-Cardoso, L. N., Campos, P. M., Otaguiri, K. K., Vicentini, F. T. M. C., Lopes, L. B., Fonseca, M. J. V., & Bentley, M. V. L. B. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.05.012 · Cited by 59
NanoEHS beyond toxicity – focusing on biocorona
Lin, S., Mortimer, M., Chen, R., Käkinen, A., Riviere, J. E., Davis, T. P., Ding, F., & Ke, P. C. (2017) · Environmental Science Nano · doi:10.1039/c6en00579a · Cited by 60
He, S., Fan, W., Wu, N., Zhu, J., Miao, Y., Miao, X., Li, F., Zhang, X., & Gan, Y. (2018) · Nano Letters · doi:10.1021/acs.nanolett.7b05430 · Cited by 59
Cell surface engineering and application in cell delivery to heart diseases
Lee, D., Cha, B.-H., Jung, M., Kim, A. S., Bull, D. A., & Won, Y. (2018) · Journal of Biological Engineering · doi:10.1186/s13036-018-0123-6 · Cited by 59
Small interfering RNA from the lab discovery to patients' recovery
Caillaud, M., Madani, M. E., & Massaad-Massade, L. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.02.032 · Cited by 60
Non-viral Gene Delivery Methods for Bone and Joints
Gantenbein, B., Tang, S. N., Guerrero, J., Higuita‐Castro, N., Salazar‐Puerta, A. I., Croft, A. S., Gazdhar, A., & Purmessur, D. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.598466 · Cited by 61
Kamanzi, A., Gu, Y., Tahvildari, R., Friedenberger, Z., Zhu, X., Berti, R., Kurylowicz, M., Witzigmann, D., Kulkarni, J. A., Leung, J., et al. (2021) · ACS Nano · doi:10.1021/acsnano.1c04862 · Cited by 58
Chien, Y., Hsiao, Y., Chou, S., Lin, T.-Y., Yarmishyn, A. A., Lai, W., Lee, M., Lin, Y., Lin, T.-W., Hwang, D., et al. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01717-x · Cited by 59
Nanobiomaterial vectors for improving gene editing and gene therapy
Hu, S. W., Ding, T., Tang, H., Guo, H., Cui, W., & Shu, Y. (2023) · Materials Today · doi:10.1016/j.mattod.2023.04.011 · Cited by 58
HA ‐ C oated Chitosan Nanoparticles for CD 44‐ M ediated Nucleic Acid Delivery
Almalik, A., Day, P. J., & Tirelli, N. (2013) · Macromolecular Bioscience · doi:10.1002/mabi.201300302 · Cited by 58
Wu, K., Song, W., Zhao, L., Liu, M., Yan, J., Andersen, M. Ø., Kjems, J., Gao, S., & Zhang, Y. (2013) · ACS Applied Materials & Interfaces · doi:10.1021/am400374c · Cited by 58
Self-citationWe still have a Long Way to go to Effectively Deliver Genes!
Pezzoli, D., Chiesa, R., Nardo, L. D., & Candiani, G. (2012) · Journal of Applied Biomaterials & Functional Materials · doi:10.5301/jabfm.2012.9707 · Cited by 61
Ewe, A., Höbel, S., Heine, C., Merz, L. M., Kallendrusch, S., Bechmann, I., Merz, F., Franke, H., & Aigner, A. M. (2016) · Drug Delivery and Translational Research · doi:10.1007/s13346-016-0306-y · Cited by 59
Baek, A., Baek, Y. M., Kim, H., Jun, B., & Kim, D. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00025 · Cited by 58
Bio-instructive materials for musculoskeletal regeneration
Gonzalez‐Fernandez, T., Sikorski, P., & Leach, J. K. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.07.014 · Cited by 59
Mulens‐Arias, V., Rojas, J. M., Sanz-Ortega, L., Portilla, Y., Pérez-Yagüe, S., & Barber, D. F. (2019) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2019.102063 · Cited by 58
AL Qtaish, N., Gallego, I., Villate-Beitia, I., Sainz-Ramos, M., López-Méndez, T. B., Grijalvo, S., Eritja, R., Soto-Sánchez, C., Martínez-Navarrete, G., Fernández, E., et al. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12030198 · Cited by 57
Lipid Nanoparticles for Nucleic Acid Delivery to Endothelial Cells
Liu, G. W., Guzman, E. B., Menon, N., & Langer, R. (2023) · Pharmaceutical Research · doi:10.1007/s11095-023-03471-7 · Cited by 58
Fattahi, A., Golozar, M. A., Varshosaz, J., Hamid, M., & Fathi, M. (2011) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2011.08.093 · Cited by 58
Spermine grafted galactosylated chitosan for improved nanoparticle mediated gene delivery
Alex, S. M., Rekha, M. R., & Sharma, C. P. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.02.067 · Cited by 57
Preparation and characterization of nonaarginine-modified chitosan nanoparticles for siRNA delivery
Park, S., Jeong, E. J., Lee, J., Rhim, T., Lee, S. K., & Lee, K. Y. (2012) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2012.08.116 · Cited by 57
Cell‐Penetrating and Neurotargeting Dendritic siRNA Nanostructures
Brunner, K., Harder, J., Halbach, T. S., Willibald, J., Spada, F., Gnerlich, F. A., Sparrer, K. M. J., Beil, A., Möckl, L., Bräuchle, C., et al. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201409803 · Cited by 58
Single quantum dot tracking reveals the impact of nanoparticle surface on intracellular state
Zahid, M. U., Ma, L., Lim, S. J., & Smith, A. M. (2018) · Nature Communications · doi:10.1038/s41467-018-04185-w · Cited by 58
Therapeutic Targeting of Neutrophil Granulocytes in Inflammatory Liver Disease
Bartneck, M., & Wang, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02257 · Cited by 58
Lipid-Nucleic Acid Complexes: Physicochemical Aspects and Prospects for Cancer Treatment
Gaspar, R., Coelho, F., & Silva, B. F. B. (2020) · Molecules · doi:10.3390/molecules25215006 · Cited by 59
DNA vaccination and gene therapy: optimization and delivery for cancer therapy
Bodles-Brakhop, A. M., & Draghia, R. (2008) · Expert Review of Vaccines · doi:10.1586/14760584.7.7.1085 · Cited by 57
Bioelectricity for Drug Delivery: The Promise of Cationic Therapeutics
Young, C. C., Vedadghavami, A., & Bajpayee, A. G. (2020) · Bioelectricity · doi:10.1089/bioe.2020.0012 · Cited by 57
Current Progress in Non-viral RNAi-Based Delivery Strategies to Lymphocytes
Mizrahy, S., Hazan‐Halevy, I., Dammes, N., Landesman‐Milo, D., & Peer, D. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.03.001 · Cited by 57
Rationale and Application of PEGylated Lipid-Based System for Advanced Target Delivery of siRNA
Ge, X., Chen, L., Zhao, B., & Yuan, W. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.598175 · Cited by 55
mRNA vaccines contribute to innate and adaptive immunity to enhance immune response in vivo
Cao, Q., Fang, H., & Tian, H. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122628 · Cited by 56
Dördelmann, G., Kozlova, D., Karczewski, S., Lizio, R., Knauer, S. K., & Epple, M. (2014) · Journal of Materials Chemistry B · doi:10.1039/c4tb00922c · Cited by 55
Mendez, N., Herrera, V., Zhang, L., Hedjran, F., Feuer, R., Blair, S. L., Trogler, W. C., Reid, T. R., & Kummel, A. C. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.08.010 · Cited by 55
Optimization of poly(amido amine)s as vectors for siRNA delivery
van der Aa, L. J., Vader, P., Storm, G., Schiffelers, R. M., & Engbersen, J. F. J. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.030 · Cited by 55
Cationic nanocarriers: A potential approach for targeting negatively charged cancer cell
Vishwakarma, M., Agrawal, P., Soni, S., Tomar, S., Haider, T., Kashaw, S. K., & Soni, V. (2024) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2024.103160 · Cited by 55
Hwang, H. S., Hu, J., Na, K., & Bae, Y. H. (2014) · Biomacromolecules · doi:10.1021/bm500843r · Cited by 54
Zhang, S., Doschak, M. R., & Uludağ, H. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.05.060 · Cited by 54
Self-citationPezzoli, D., & Candiani, G. (2013) · Journal of Nanoparticle Research · doi:10.1007/s11051-013-1523-7 · Cited by 55
Hisamatsu, Y., Shibuya, A., Suzuki, N., Suzuki, T., Abe, R., & Aoki, S. (2015) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5b00095 · Cited by 54
Lipid-encapsulated siRNA for hepatocyte-directed treatment of advanced liver disease
Woitok, M. M., Zoubek, M. E., Doleschel, D., Bartneck, M., Mohamed, M. R., Kießling, F., Lederle, W., Trautwein, C., & Cubero, F. J. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-2571-4 · Cited by 53
Lipid nanoparticles for RNA delivery: Self-assembling vs driven-assembling strategies
Nele, V., Campani, V., Moosavian, S. A., & Rosa, G. D. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115291 · Cited by 58
Acharya, S., & Hill, R. A. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.07.015 · Cited by 53
Polycation-based nanoparticle delivery for improved RNA interference therapeutics
Howard, K. A., & Kjems, J. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.12.1811 · Cited by 55
Leung, H. M., Chan, M. S., Liu, L. S., Wong, S. W., Lo, T. W., Lau, C., Tin, C., & Lo, P. K. (2018) · ACS Sustainable Chemistry & Engineering · doi:10.1021/acssuschemeng.8b00446 · Cited by 53
Insights into gold nanoparticles as a mucoadhesive system
Ouellette, M., Masse, F., Lefebvre-Demers, M., Maestracci, Q., Grenier, P., Millar, R. P., Bertrand, N., PRIETO, M. J. E., & Boisselier, É. (2018) · Scientific Reports · doi:10.1038/s41598-018-32699-2 · Cited by 54
Sinani, G., Sessevmez, M., Gök, M. K., Özgümüş, S., Alpar, H. O., & Cevher, E. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118592 · Cited by 53
Mucker, E. M., Karmali, P. P., Vega, J. B., Kwilas, S. A., Wu, H., Joselyn, M., Ballantyne, J. A., Sampey, D. B., Mukthavaram, R., Sullivan, E. J., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-65059-0 · Cited by 53
Efficient Extracellular Vesicles Freeze-Dry Method for Direct Formulations Preparation and Use
Guarro, M., Suñer, F., Lecina, M., Borrós, S., & Fornaguera, C. (2021) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2022.112745 · Cited by 52
Advances in mRNA therapeutics for cancer immunotherapy: From modification to delivery
Han, G., Noh, D., Lee, H., Lee, S., Kim, S., Yoon, H. Y., & Hyeon, L. S. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114973 · Cited by 53
Lysine-based polycation:heparin coacervate for controlled protein delivery
Johnson, N. R., Ambe, T., & Wang, Y. (2013) · Acta Biomaterialia · doi:10.1016/j.actbio.2013.09.012 · Cited by 52
Zhang, H., & Vinogradov, S. V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.01.020 · Cited by 52
Nanoparticles Electrostatically Coated with Folic Acid for Effective Gene Therapy
Kurosaki, T., Morishita, T., Kodama, Y., Sato, K., Nakagawa, H., Higuchi, N., Nakamura, T., Hamamoto, T., Sasaki, H., & Kitahara, T. (2011) · Molecular Pharmaceutics · doi:10.1021/mp2001268 · Cited by 52
Sonoporation of the Minicircle-VEGF165 for Wound Healing of Diabetic Mice
Yoon, C. S., Jung, H. S., Kwon, M. J., Lee, S. Y., Kim, C. W., Kim, M.-K., Lee, M., & Park, J. H. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9778-x · Cited by 52
RNAi nanomedicines: challenges and opportunities within the immune system
Weinstein, S., & Peer, D. (2010) · Nanotechnology · doi:10.1088/0957-4484/21/23/232001 · Cited by 52
Novel chitosan based nanoparticles as gene delivery systems to cancerous and noncancerous cells
Rahmani, S., Hakimi, S., Esmaeily, A., Samadi, F., Mortazavian, E., Nazari, M., Mohammadi, Z., Tehrani, N. R., & Tehrani, M. R. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.02.016 · Cited by 52
Metadata
- Authors
- Lv, H., Zhang, S., Wang, B., Cui, S., & Yan, J.
- Affiliations
- Dalian Institute of Chemical Physics (CN)
- Dalian Minzu University (CN)
- Sichuan University of Science and Engineering (CN)
- Corresponding author
- Zhang, Shubiao
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2006-08
- Volume
- 114
- Issue
- 1
- Pages
- 100-109
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2000136129
- Cited by
- 2,286
- References
- 107
- Citations by year
- 2026: 100 · 2025: 123 · 2024: 163 · 2023: 141 · 2022: 146 · 2021: 149 · 2020: 140 · 2019: 168 · 2018: 129 · 2017: 133 · 2016: 124 · 2015: 126 · 2014: 147 · 2013: 117 · 2012: 97
- FWCI
- 3.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Controlled Release (publishedVersion)
- PubMed (publishedVersion)
- Dalian Institute of Chemical Physics, CAS Institutional Repository (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- cationic lipids, cationic polymers, gene delivery, non-viral vectors, toxicity, structure-toxicity relationship, gene therapy, cationic compounds
- MeSH terms
- Animals, Cations, Lipids, Liposomes, Polylysine, Polymers, Polysaccharides, Genetic Therapy, Molecular Structure
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review